A carregar...
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy
COPD is characterized by persistent airflow obstruction caused by exposure to irritants including cigarette smoke, dust, and fumes. According to the latest GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines, a combination of inhaled corticosteroids, long-acting β(2) agonists, a...
Na minha lista:
Publicado no: | Int J Chron Obstruct Pulmon Dis |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5221559/ https://ncbi.nlm.nih.gov/pubmed/28115838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S114273 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|